image
Evoke Pharma, Inc. EVOK
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 4.58
4.33 %
$ 6.81 M
Market Cap
-0.45
P/E
INCOME STATEMENT
5.18 M REVENUE
106.51%
Growth Rates
1Year 106.51%
3Years 508.26%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-7.43 M OPERATING INCOME
4.56%
Growth Rates
1Year 4.56%
3Years 17.11%
5Years 1.50%
7Years 4.88%
10Years -11.06%
-7.79 M NET INCOME
5.25%
Growth Rates
1Year 5.25%
3Years 16.02%
5Years -0.59%
7Years 4.49%
10Years -10.63%
EFFICIENCY
Earnings Waterfall Evoke Pharma, Inc.
image
Revenue 5.18 M
Cost Of Revenue 202 K
Gross Profit 4.98 M
Operating Expenses 12.4 M
Operating Income -7.43 M
Other Expenses 361 K
Net Income -7.79 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 5.2 2.5 1.6 23 K 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0.2 0.4 0.3 86.7 K 0 0 0 0 0 0 0 0 0
Gross Profit 5.0 2.1 1.3 63.7 K 0 0 0 0 0 0 0 0 0
OPERATING INCOME
Operating Expenses 12.4 9.9 9.4 13.0 7.2 8.0 11.2 10.5 11.8 13.2 2.6 2.0 2.4
Selling, General and Administrative Expenses 12.2 9.6 8.9 6.4 3.7 3.9 4.1 3.6 3.7 3.2 1.6 0.8 0.6
Research and Development Expenses 0.2 0.3 0.6 6.6 3.4 4.1 7.1 7.0 8.2 10.0 1.0 1.2 1.8
Operating Income (7.4) (7.8) (8.2) (13.0) (7.2) (8.0) (11.2) (10.5) (11.8) (13.2) (2.6) (2.0) (2.4)
PRE-TAX INCOME
Interest Income Expense 0.5 0.5 0.5 0.1 0 15.2 K 6.52 K (0.8) 0 0.1 0.2 24 K 2.87 K
Total Other Income (0.4) (0.4) (0.4) (0.1) 28.8 K 0.4 (1.0) (0.2) (0.3) 97.6 K (0.2) 15.1 K 13.3 K
Pre-Tax Income (7.8) (8.2) (8.5) (13.2) (7.1) (7.6) (12.2) (10.7) (12.1) (13.2) (2.8) (2.0) (2.4)
NET INCOME
Tax Provision 0 62 K 0.5 0.1 28.8 K (0.9) 6.52 K 0.8 0 0 0.2 22.4 K 7.82 K
Net Income (7.8) (8.2) (9.0) (13.3) (7.1) (7.6) (12.2) (10.7) (12.1) (13.2) (2.8) (2.0) (2.4)
EPS 28 31.4 38.2 74.3 46 65.6 118 166 269 317 173 234 9.7